Have a personal or library account? Click to login
Nailfold capillaroscopy in systemic diseases: short overview for internal medicine Cover

Nailfold capillaroscopy in systemic diseases: short overview for internal medicine

Open Access
|Aug 2021

References

  1. 1. KAYSER C., BREDEMEIER M., CALEIRO MT., CAPOBIANCO K., FERNANDES TM., DE ARAUJO FONTENELE SM., et al. Position article and guidelines 2018 recommendations of the Brazilian Society of Rheumatology for the indication, interpretation and performance of nailfold capillaroscopy. Adv Rheumatol. 2019;59(5):1–13.10.1186/s42358-018-0046-4
  2. 2. CUTOLO M., SMITH V. Nailfold capillaroscopy. Scleroderma: From Pathogenesis to Comprehensive Management. Springer US; 2012. p. 331–46.10.1007/978-1-4419-5774-0_27
  3. 3. CUTOLO M., MELSENS K., HERRICK AL., FOELDVARI I., DESCHEPPER E., DE KEYSER F., et al. Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases. Rheumatol (United Kingdom). 2018;57(4):757–9.10.1093/rheumatology/kex460
  4. 4. BERTOLAZZI C., VARGAS GUERRERO A., RODRÍGUEZ-REYNA TS., SANDOVAL H., ÁLVAREZ-HERNÁNDEZ E., AUDISIO MJ., et al. Pan-American League of Associations for Rheumatology (PANLAR) capillaroscopy study group consensus for the format and content of the report in capillaroscopy in rheumatology. Clin Rheumatol. 2019;38(9):2327–37.10.1007/s10067-019-04610-5
  5. 5. CUTOLO M. Atlas of capillaroscopy in rheumatic diseases. Elsevier 2010:25–43.
  6. 6. BUCHANAN IS., HUMPSTON DJ. Nail-fold capillaries in connective-tissue disorders. Lancet. 1968;291(7547):845–7.10.1016/S0140-6736(68)90302-4
  7. 7. MARICQ HR., CARWILE LEROY E. Patterns of finger capillary abnormalities in connective tissue disease by “wide-field” microscopy. Arthritis Rheum. 1973;16(5):619–28.10.1002/art.1780160506
  8. 8. FAGGIOLI P., TAMBURELLO A., SCIASCERA A., GILARDI AG., MAZZONE A. Nailfold videocapillaroscopy in internal medicine. Ital J Med. 2015;9(3):234–42.10.4081/itjm.2015.548
  9. 9. MARICQ HR., MAIZE JC. Nailfold capillary abnormalities. Vol. 8, Clinics in Rheumatic Diseases. 1982. p. 455–78.10.1016/S0307-742X(21)00396-9
  10. 10. CUTOLO M., SULLI A., PIZZORNI C., ACCARDO S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27(1):155–60.
  11. 11. EMRANI Z., KARBALAIE A., FATEMI A., ETEHADTAVAKOL M., ERLANDSSON BE. Capillary density: An important parameter in nailfold capillaroscopy. Microvasc Res [Internet]. 2017;109:7–18. Available from: http://dx.doi.org/10.1016/j.mvr.2016.09.00110.1016/j.mvr.2016.09.00127614146
  12. 12. CUTOLO M., SMITH V. State of the art on nailfold capillaroscopy: A reliable diagnostic tool and putative biomarker in rheumatology? Rheumatol (United Kingdom). 2013;52(11):1933–40.
  13. 13. VAN DEN HOOGEN F., KHANNA D., FRANSEN J., JOHNSON SR., BARON M., TYNDALL A., et al. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 2013;65(11):2737–47.10.1002/art.38098393014624122180
  14. 14. PAXTON D., PAULING JD. Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Semin Arthritis Rheum 2018;48:482–94. doi:10.1016/j.semarthrit.2018.02.00510.1016/j.semarthrit.2018.02.00529602558
  15. 15. SMITH V., HERRICK AL., INGEGNOLI F., DAMJANOV N., ANGELIS, DENTON CP., et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev [Internet]. 2020;(xxxx):102458. Available from: https://doi.org/10.1016/j.autrev.2020.10245810.1016/j.autrev.2020.10245831927087
  16. 16. CUTOLO M., SULLI A., SMITH V. How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol. 2013; 27(2):237–48.10.1016/j.berh.2013.03.00123731933
  17. 17. ROLDAN LMC., FRANCO CJV., NAVAS MAM. Capillaroscopy in systemic sclerosis: A narrative literature review. Rev Colomb Reumatol. 2016;23(4):250–8.
  18. 18. INGEGNOLI F., GUALTIEROTTI R., LUBATTI C., BERTOLAZZI C., GUTIERREZ M., BORACCHI P., et al. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy. Microvasc Res. 2013;90:90–5.10.1016/j.mvr.2013.07.00123880032
  19. 19. TAVAKOL ME., FATEMI A., KARBALAIE A., EMRANI Z., ERLANDSSON BE. Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated? Biomed Res Int. 2015: 974530.10.1155/2015/974530456978326421308
  20. 20. INGEGNOLI F., GUALTIEROTTI R. A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis. Expert Rev Clin Immunol. 2013;9(11):1091–7.10.1586/1744666X.2013.84919824147535
  21. 21. CUTOLO M., MELSENS K., TROMBETTA A., PIZZORNI C., DESCHEPPER E., SULLI A., et al. SAT0377 Reliability of a new automated system for absolute capillary number counting (AUTOCAPI) on systemic sclerosis nailfold videocapillaroscopic images. Annals of the Rheumatic Diseases. BMJ; 2017. p. 914.1-914.10.1136/annrheumdis-2017-eular.3191
  22. 22. CUTOLO M., TROMBETTA AC., MELSENS K., PIZZORNI C., SULLI A., RUARO B., et al. Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis. Microcirculation 2018 May;25(4):e12447.10.1111/micc.1244729527781
  23. 23. SELVA-O’CALLAGHAN A., FONOLLOSA-PLA V., TRALLERO-ARAGUÁS E., MARTÍNEZ-GÓMEZ X., SIMEONAZNAR CP., LABRADOR-HORRILLO M., et al. Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum. 2010;39(5):398–404.10.1016/j.semarthrit.2008.09.00319022479
  24. 24. LIN KM., CHENG TT., CHEN CJ. Clinical applications of nailfold capillaroscopy in different rheumatic diseases. J Intern Med Taiwan. 2009;20(3):238–47.
  25. 25. SOUBRIER C., SEGUIER J., DI COSTANZO MP., EBBO M., BERNIT E., JEAN E., et al. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy. Clin Rheumatol. 2019;38(12):3451–8.10.1007/s10067-019-04710-231440919
  26. 26. MIHAI C., SMITH V., DOBROTA R., et al. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis. Microvasc. Res. 2018;118:113–20. doi:10.1016/j.mvr.2018.03.00
  27. 27. MANFREDI A., SEBASTIANI M., CASSONE G., PIPITONE N., GIUGGIOLI D., COLACI M., et al. Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol. 2015;34(2):279–84.10.1007/s10067-014-2795-825318613
  28. 28. KAYSER C., SEKIYAMA JY., PRÓSPERO LC., CAMARGO CZ., ANDRADE LEC. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol. 2013;31(SUPPL.76).
  29. 29. CUTOLO M., MELSENS K., WIJNANT S., INGEGNOLI F., THEVISSEN K., DE KEYSER F., et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun Rev. 2018;17(4):344–52.10.1016/j.autrev.2017.11.02529427827
  30. 30. CHOJNOWSKI MM., FELIS-GIEMZA A., OLESIŃSKA. Capillaroscopy – A role in modern rheumatology. Reumatologia. 2016;54(2):67–72.
  31. 31. INGEGNOLI F., BORACCHI P., GUALTIEROTTI R., LUBATTI C., MEANI L., ZAHALKOVA L., et al. Prognostic model based on nailfold capillaroscopy for identifying Raynaud’s phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (Prognostic Index for Nailfold Capillaroscopic Examination). Arthritis Rheum. 2008;58(7):2174–82.10.1002/art.2355518576359
  32. 32. INGEGNOLI F., BORACCHI P., GUALTIEROTTI R., BIGANZOLI EM., ZENI S., LUBATTI C., et al. Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford). 2010;49(4):797–805.10.1093/rheumatology/kep44720100796
  33. 33. KOENIG M., JOYAL F., FRITZLER M.J., et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902–12. doi:10.1002/art.2403810.1002/art.2403819035499
  34. 34. BERTOLAZZI C., CUTOLO M., SMITH V., GUTIERREZ M. State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis. Semin Arthritis Rheum. 2017;47(3):432–44.10.1016/j.semarthrit.2017.06.00128668440
  35. 35. JEE AS., ADELSTEIN S., BLEASEL J., KEIR GJ., NGUYEN M., SAHHAR J., et al. Clinical Medicine Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). J Clin Med. 2017 May 4;6(5):51.10.3390/jcm6050051544794228471413
  36. 36. AVOUAC J., FRANSEN J., WALKER UA., RICCIERI V., SMITH V., MULLER C., et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi consensus study from EULAR scleroderma trials and research group. Ann Rheum Dis. 2011;70(3):476–81.10.1136/ard.2010.13692921081523
  37. 37. ØSTENSEN M., ANDREOLI L., BRUCATO A., CETIN I., CHAMBERS C., CLOWSE MEB., et al. State of the art: Reproduction and pregnancy in rheumatic diseases. Autoimmun Rev. 2015;14(5):376–86.10.1016/j.autrev.2014.12.01125555818
  38. 38. SULLI A., SECCHI M.E., PIZZORNI C., CUTOLO M. Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis. 2008; 67(6):885–7.10.1136/ard.2007.07975618037628
  39. 39. SMITH V., VANHAECKE A., HERRICK A.L., et al. Fast track algorithm: How to differentiate a “scleroderma pattern” from a “non-scleroderma pattern”. Autoimmun. Rev. 2019;18. doi:10.1016/j.autrev.2019.10239410.1016/j.autrev.2019.10239431520797
  40. 40. RICCIERI V., VASILE M., IANNACE N., STEFANANTONI K., SCIARRA I., VIZZA CD., et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: A nailfold capillaroscopy study. Rheumatol (United Kingdom). 2013;52(8):1525–8.10.1093/rheumatology/ket16823671125
  41. 41. SCUSSEL-LONZETTI L., JOYAL F., RAYNAULD JP., ROUSSIN A., RICH É., GOULET JR., et al. Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002;81(2):154–67.10.1097/00005792-200203000-0000511889414
  42. 42. GUILLEN-DEL-CASTILLO A., SIMEON-AZNAR CP., CALLEJAS-MORAGA EL., TOLOSA-VILELLA C., ALONSOVILA S., FONOLLOSA-PLA V., et al. Quantitative videocapillaroscopy correlates with functional respiratory parameters: A clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis. Arthritis Res Ther. 2018;20(1):1–10.10.1186/s13075-018-1775-9629995730567570
  43. 43. SEBASTIANI M., MANFREDI A., COLACI M., DAMICO R., MALAGOLI V., GIUGGIOLI D., et al. Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Care Res. 2009;61(5):688–94.10.1002/art.2439419405007
  44. 44. PIGNATARO F., MAGLIONE W., MINNITI A., SAMBATARO D., SAMBATARO G., CAMPANARO F., et al. NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity. Arthritis Res Ther. 2019;21(1):1–8.10.1186/s13075-019-2032-6688488931783890
  45. 45. FRIEDRICH S., LÜDERS S., KLOTSCHE J., et al. The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history–CIP-DUS. Arthritis Res Ther. 2020;22(1):1–6.10.1186/s13075-020-02235-7729466132539806
  46. 46. DE ANGELIS R., CERIONI A., DEL MEDICO P., BLASETTI P. Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD). Clin Rheumatol. 2005;24(2):145–51.10.1007/s10067-004-0988-215351873
  47. 47. GARCÍA-GONZÁLEZ M., RODRÍGUEZ-LOZANO B., BUSTABAD S., FERRAZ-AMARO I. Undifferentiated connective tissue disease: Predictors of evolution into definite disease. Clin Exp Rheumatol. 2017;35(5):739–45.
  48. 48. VALENTINI G., VETTORI S., CUOMO G., IUDICI M., D’ABROSCA V., CAPOCOTTA D., et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther. 2012;14(4):R188.10.1186/ar4019358058422901779
  49. 49. DIMA A., JURCUT C., BAICUS C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatology International. 2018.10.1007/s00296-018-4059-429796907
  50. 50. DIÓGENES ADHM., BONFÁ E., FULLER R., CALEIRO MTC. Capillaroscopy is a dynamic process. Lupus. 2007;16(4):254–8.10.1177/096120330707651717439931
  51. 51. CIANG NCO., PEREIRA N., ISENBERG DA. Mixed connective tissue disease-enigma variations? Rheumatology (Oxford). 2017 Mar 1;56(3):326–333
  52. 52. PAOLINO S., FERRARI G., PIZZORNI C., PATANE M., SMITH V., CUTOLO M., et al. Long-term follow-up of nailfold videocapillaroscopic microvascular parameters in mixed connective tissue disease versus systemic sclerosis patients: a retrospective cohort study. Clin Exp Rheumatol. 2019;37 Suppl 119(4):102-107.
  53. 53. MARICQ HR., LEROY EC., D’ANGELO WA., MEDSGER TA., RODNAN GP., SHARP GC., et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980; 23(2):183–9.10.1002/art.17802302087362667
  54. 54. GRANIER F., VAYSSAIRAT M., PRIOLLET P., HOUSSET E. Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum. 1986;29(2):189–95.10.1002/art.17802902063954804
  55. 55. CIANG NCO., PEREIRA N., ISENBERG DA. Mixed connective tissue disease-enigma variations? Rheumatology (Oxford). 2017 Mar 1;56(3):326–333.
  56. 56. CELINSKA-LÖWENHOFF M., PASTUSZCZAK M., PELKA K., STEC-POLAK M., WOJAS-PELC A., MUSIAL J. Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease. Arch Med Sci. 2020;16(2):297–301.10.5114/aoms.2018.81129706942032190139
  57. 57. ASCHWANDEN M., DAIKELER T., JAEGER KA., THALHAMMER C., GRATWOHL A., MATUCCI-CERINIC M., et al. Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis. 2008 Jul;67(7):1057–9.10.1136/ard.2007.08200818556454
  58. 58. OLDROYD A., LILLEKER J., CHINOY H. Idiopathic inflammatory myopathies–a guide to subtypes, diagnostic approach and treatment. Clin Med J R Coll. Physicians London. 2017;17:322–8. doi:10.7861/clinmedicine.17-4-32210.7861/clinmedicine.17-4-322629764928765407
  59. 59. VAZ JLP., DANCOUR MAA., BOTTINO DA., BOUSKELA E. Nailfold videocapillaroscopy in primary antiphospholipid syndrome (PAPS). Rheumatology. 2004;43(8):1025–7.10.1093/rheumatology/keh23315187240
  60. 60. CANDELA M., PANSONI A., DE CAROLIS ST., POMPONIO G., CORVETTA A., GABRIELLI A., et al. Nailfold capillary microscopy in patients with antiphospholipid syndrome. Recenti Prog Med. 1998;89(9).
  61. 61. RAEESKARAMI SR., NAMAZI N., ASSARI R., NAJAFIZADEH SR., HASSANNEJAD Z., ZIAEE V. The Comparison of Nailfold Capillaroscopy between Juvenile Systemic Lupus Erythematosus and Healthy Controls: Correlation with Laboratory and Clinical Parameters. Int J Vasc Med. 2020;2020.10.1155/2020/7631958720180632395346
  62. 62. LIN KM., CHENG TT., CHEN CJ. Clinical Applications of Nailfold Capillaroscopy in Different Rheumatic Diseases. Gung Memorial Hospital C. 2009;20:238–247.
  63. 63. ASLANIDIS S., PYRPASOPOULOU A., DOUMAS M., TRIANTAFYLLOU A., CHATZIMICHAILIDOU S., ZAMBOULIS C. Association of capillaroscopic microhaemorrhages with clinical and immunological antiphospholipid syndrome. Clin Exp Rheumatol. 2011;29(2):307–9.
  64. 64. PYRPASOPOULOU A., TRIANTAFYLLOU A., ANYFANTI P., DOUMA S., ASLANIDIS S. Capillaroscopy as a screening test for clinical antiphospholipid syndrome. Eur J Intern Med. 2011;22(6):e158–9.10.1016/j.ejim.2011.07.00722075311
  65. 65. FAGGIOLI P., TAMBURELLO A., SCIASCERA A., GILARDI AG., MAZZONE A. Nailfold videocapillaroscopy in internal medicine. Italian Journal of Medicine. Vol. 9. Page Press Publications; 2015;9:234–42.
  66. 66. CAPOBIANCO KG., XAVIER RM., BREDEMEIER M., RESTELLI VG., BRENOL JCT. Nailfold capillaroscopic findings in primary Sjögren’s syndrome: Clinical and serological correlations. Clin Exp Rheumatol. 2005;23(6):789–94.
  67. 67. COROMINAS H., ORTIZ-SANTAMARIA V., CASTELLVI I., MORENO M., MORLA R., CLAVAGUERA T., et al. Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int. 2016;36(3):365–9.10.1007/s00296-015-3396-926597492
  68. 68. TEKTONIDOU M., KASKANI E., SKOPOULI FN., MOUTSOPOULOS HM. Microvascular abnormalities in Sjogren’s syndrome: Nailfold capillaroscopy. Rheumatology. 1999;38(9):826–30.10.1093/rheumatology/38.9.82610515642
  69. 69. SZABO N., CSIKI Z., SZANTO A., DANKO K., SZODORAY P., ZEHER M. Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud’s and Sjögren’s syndrome and poly/dermatomyositis. Scand J Rheumatol. 2008;37(1):23–9.10.1080/0300974070164020918189191
  70. 70. AGUIAR T., FURTADO E., DORIGO D., BOTTINO D., BOUSKELA E. Nailfold videocapillaroscopy in primary sjögren’s syndrome. Angiology. 2006;57(5):593–9.10.1177/000331970629312717067982
  71. 71. OHTSUKA T. Nailfold capillary abnormalities in patients with Sjogren’s syndrome and systemic lupus erythematosus. Br J Dermatol. 1997;136(1):94–6.10.1111/j.1365-2133.1997.tb08753.x
  72. 72. SCOFIELD RH. Vasculitis in Sjögren’s Syndrome. Curr Rheumatol Rep. 2011 Dec; 13(6): 482–488.10.1007/s11926-011-0207-5527861821870104
  73. 73. BHUSHAN M., MOORE T., HERRICK AL., GRIFFITHS CEM. Nailfold video capillaroscopy in psoriasis. Br J Dermatol. 2000;142(6):1171–6.10.1046/j.1365-2133.2000.03544.x10848742
  74. 74. GRACEFFA D., AMOROSI B., MAIANI E., BONIFATI C., CHIMENTI MS., PERRICONE R., et al. Capillaroscopy in psoriatic and rheumatoid arthritis: A useful tool for differential diagnosis. Arthritis. 2013;2013:957480.10.1155/2013/957480387435324396598
  75. 75. LAMBOVA SN., MÜLLER-LADNER U. Capillaroscopic pattern in inflammatory arthritis. Microvasc Res. 2012;83(3):318–22.10.1016/j.mvr.2012.03.002333215322426123
  76. 76. RIBEIRO CF., SIQUEIRA EBD., HOLLER AP., FABRÍCIO L., SKARE TL. Capilaroscopia periungueal em psoríase. An Bras Dermatol. 2012;87(4):550–3.10.1590/S0365-0596201200040000522892767
  77. 77. UREYEN SB., KARA RO., ERTURK Z., YALDIZ M. The microvascular and morphostructural changes of nails in psoriatic patients with nail disease; A link between ultrasound and videocapillaroscopy findings in the nailfold. Med Ultrason. 2018;20(2):185–91.10.11152/mu-127429730685
  78. 78. MUSUMECI ML., LACARRUBBA F., FUSTO CM., MICALI G. Combined clinical, capillaroscopic and ultrasound evaluation during treatment of plaque psoriasis with oral cyclosporine. Int J Immunopathol Pharmacol. 2013;26(4):1027–33.10.1177/03946320130260042524355242
  79. 79. SAG S., SAG MS., TEKEOGLU I., KAMANLI A., NAS K., AYDIN Y. Nailfold videocapillaroscopy results in patients with rheumatoid arthritis. Clin Rheumatol. 2017;36(9):1969–74.10.1007/s10067-017-3696-428578493
  80. 80. MCGILL NW., GOW PJ. Nailfold Capillaroscopy: a Blinded Study of Its Discriminatory Value in Scleroderma, Systemic Lupus Erythematosus, and Rheumatoid Arthritis. Aust N Z J Med. 1986;16(4):457–60.10.1111/j.1445-5994.1986.tb02010.x3467690
  81. 81. FLOREA M., ROŞU A., VREJU FA., MUŞETESCU AE., CRIVEANU C., CIUREA P. Contribution of Nail Fold Videocapillaroscopy in Patients with Early Inflammatory Arthritis. Curr Heal Sci J. 2015;41(3):233–8.
  82. 82. RAJAEI A., DEHGHAN P., AMIRI A. Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Casp J Intern Med. 2017;8(4):269–75.
  83. 83. ANYFANTI P., GKALIAGKOUSI E., TRIANTAFYLLOU A., ZABULIS X., DOLGYRAS P., GALANOPOULOU V., et al. Dermal capillary rarefaction as a marker of microvascular damage in patients with rheumatoid arthritis: Association with inflammation and disorders of the macrocirculation. Microcirculation. 2018;25(5):0–2.10.1111/micc.1245129734516
DOI: https://doi.org/10.2478/rjim-2021-0007 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 201 - 217
Submitted on: Dec 3, 2020
Published on: Aug 26, 2021
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Alina Dima, Ioana Berza, Daniela Nicoleta Popescu, Magda Ileana Parvu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.